{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:01:59Z","timestamp":1794535319826,"version":"4.9.1"},"reference-count":178,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Microbiol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1038\/s41579-023-00871-9","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T17:29:00Z","timestamp":1678814940000},"page":"463-477","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":316,"title":["Crimean\u2013Congo haemorrhagic fever virus"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8233-8176","authenticated-orcid":false,"given":"David W.","family":"Hawman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9448-8227","authenticated-orcid":false,"given":"Heinz","family":"Feldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,14]]},"reference":[{"key":"871_CR1","first-page":"86","volume":"44","author":"DI Simpson","year":"1967","unstructured":"Simpson, D. I. et al. Congo virus: a hitherto undescribed virus occurring in Africa. I. Human isolations\u2013clinical notes. East Afr. Med. J. 44, 86\u201392 (1967).","journal-title":"East Afr. Med. J."},{"key":"871_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3181\/00379727-131-33847","volume":"131","author":"J Casals","year":"1969","unstructured":"Casals, J. Antigenic similarity between the virus causing Crimean hemorrhagic fever and Congo virus. Proc. Soc. Exp. Biol. Med. 131, 233\u2013236 (1969).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"871_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/trstmh\/trv050","volume":"109","author":"JP Messina","year":"2015","unstructured":"Messina, J. P. et al. The global distribution of Crimean-Congo hemorrhagic fever. Trans. R. Soc. Trop. Med. Hyg. 109, 503\u2013513 (2015).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"871_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.antiviral.2017.05.010","volume":"144","author":"A Gargili","year":"2017","unstructured":"Gargili, A. et al. The role of ticks in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus: a review of published field and laboratory studies. Antivir. Res. 144, 93\u2013119 (2017).","journal-title":"Antivir. Res."},{"key":"871_CR5","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.3201\/eid1812.120718","volume":"18","author":"M Lindeborg","year":"2012","unstructured":"Lindeborg, M. et al. Migratory birds, ticks, and Crimean-Congo hemorrhagic fever virus. Emerg. Infect. Dis. 18, 2095\u20132097 (2012).","journal-title":"Emerg. Infect. Dis."},{"key":"871_CR6","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/jme\/tjy006","volume":"55","author":"T Rainey","year":"2018","unstructured":"Rainey, T., Occi, J. L., Robbins, R. G. & Egizi, A. Discovery of Haemaphysalis longicornis (Ixodida: Ixodidae) parasitizing a sheep in New Jersey, United States. J. Med. Entomol. 55, 757\u2013759 (2018).","journal-title":"J. Med. Entomol."},{"key":"871_CR7","doi-asserted-by":"publisher","first-page":"101403","DOI":"10.1016\/j.ttbdis.2020.101403","volume":"11","author":"G Grandi","year":"2020","unstructured":"Grandi, G. et al. First records of adult Hyalomma marginatum and H. rufipes ticks (Acari: Ixodidae) in Sweden. Ticks Tick Borne Dis. 11, 101403 (2020).","journal-title":"Ticks Tick Borne Dis."},{"key":"871_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004210","volume":"10","author":"JR Spengler","year":"2016","unstructured":"Spengler, J. R., Bergeron, \u00c9. & Rollin, P. E. Seroepidemiological studies of Crimean-Congo hemorrhagic fever virus in domestic and wild animals. PLoS Negl. Trop. Dis. 10, e0004210 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"871_CR9","doi-asserted-by":"publisher","first-page":"576","DOI":"10.4269\/ajtmh.1993.48.576","volume":"48","author":"SW Gordon","year":"1993","unstructured":"Gordon, S. W., Linthicum, K. J. & Moulton, J. R. Transmission of Crimean-Congo hemorrhagic fever virus in two species of Hyalomma ticks from infected adults to cofeeding immature forms. Am. J. Trop. Med. Hyg. 48, 576\u2013580 (1993).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"871_CR10","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1099\/jgv.0.001485","volume":"101","author":"AR Garrison","year":"2020","unstructured":"Garrison, A. R. et al. ICTV virus taxonomy profile: Nairoviridae. J. Gen. Virol. 101, 798\u2013799 (2020).","journal-title":"J. Gen. Virol."},{"key":"871_CR11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1017\/S0950268800052687","volume":"116","author":"FJ Burt","year":"1996","unstructured":"Burt, F. J., Spencer, D. C., Leman, P. A., Patterson, B. & Swanepoel, R. Investigation of tick-borne viruses as pathogens of humans in South Africa and evidence of Dugbe virus infection in a patient with prolonged thrombocytopenia. Epidemiol. Infect. 116, 353\u2013361 (1996).","journal-title":"Epidemiol. Infect."},{"key":"871_CR12","doi-asserted-by":"crossref","unstructured":"Guu, T. S. Y., Zheng, W. & Tao, Y. J. in Viral Molecular Machines (eds Rossmann, M. G. & Rao, V. B.) 245\u2013266 (Springer, 2012).","DOI":"10.1007\/978-1-4614-0980-9_11"},{"key":"871_CR13","doi-asserted-by":"publisher","first-page":"10914","DOI":"10.1128\/JVI.01555-12","volume":"86","author":"SD Carter","year":"2012","unstructured":"Carter, S. D. et al. Structure, function, and evolution of the Crimean-Congo hemorrhagic fever virus nucleocapsid protein. J. Virol. 86, 10914\u201310923 (2012).","journal-title":"J. Virol."},{"key":"871_CR14","doi-asserted-by":"publisher","first-page":"5046","DOI":"10.1073\/pnas.1200808109","volume":"109","author":"Y Guo","year":"2012","unstructured":"Guo, Y. et al. Crimean\u2013Congo hemorrhagic fever virus nucleoprotein reveals endonuclease activity in bunyaviruses. Proc. Natl Acad. Sci. USA 109, 5046\u20135051 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"871_CR15","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00636-17","author":"S Jeeva","year":"2017","unstructured":"Jeeva, S., Cheng, E., Ganaie, S. S. & Mir, M. A. Crimean-Congo hemorrhagic fever virus nucleocapsid protein augments mRNA translation. J. Virol. https:\/\/doi.org\/10.1128\/jvi.00636-17 (2017).","journal-title":"J. Virol."},{"key":"871_CR16","doi-asserted-by":"publisher","first-page":"9305","DOI":"10.1128\/JVI.00661-16","volume":"90","author":"R Surtees","year":"2016","unstructured":"Surtees, R. et al. Heat shock protein 70 family members interact with Crimean-Congo hemorrhagic fever virus and Hazara virus nucleocapsid proteins and perform a functional role in the nairovirus replication cycle. J. Virol. 90, 9305\u20139316 (2016).","journal-title":"J. Virol."},{"key":"871_CR17","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1074\/jbc.M110.149369","volume":"286","author":"H Karlberg","year":"2011","unstructured":"Karlberg, H., Tan, Y.-J. & Mirazimi, A. Induction of caspase activation and cleavage of the viral nucleocapsid protein in different cell types during Crimean-Congo hemorrhagic fever virus infection. J. Biol. Chem. 286, 3227\u20133234 (2011).","journal-title":"J. Biol. Chem."},{"key":"871_CR18","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1099\/jgv.0.000011","volume":"96","author":"H Karlberg","year":"2015","unstructured":"Karlberg, H., Tan, Y.-J. & Mirazimi, A. Crimean\u2013Congo haemorrhagic fever replication interplays with regulation mechanisms of apoptosis. J. Gen. Virol. 96, 538\u2013546 (2015).","journal-title":"J. Gen. Virol."},{"key":"871_CR19","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1074\/jbc.M115.667436","volume":"291","author":"B Barnwal","year":"2016","unstructured":"Barnwal, B., Karlberg, H., Mirazimi, A. & Tan, Y.-J. The non-structural protein of Crimean-Congo hemorrhagic fever virus disrupts the mitochondrial membrane potential and induces apoptosis. J. Biol. Chem. 291, 582\u2013592 (2016).","journal-title":"J. Biol. Chem."},{"key":"871_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029712","volume":"7","author":"R Rodrigues","year":"2012","unstructured":"Rodrigues, R., Paranhos-Baccal\u00e0, G., Vernet, G. & Peyrefitte, C. N. Crimean-Congo hemorrhagic fever virus-infected hepatocytes induce ER-stress and apoptosis crosstalk. PLoS ONE 7, e29712 (2012).","journal-title":"PLoS ONE"},{"key":"871_CR21","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01083-18","author":"ME Lindquist","year":"2018","unstructured":"Lindquist, M. E. et al. Exploring Crimean-Congo hemorrhagic fever virus-induced hepatic injury using antibody-mediated type I interferon blockade in mice. J. Virol. https:\/\/doi.org\/10.1128\/jvi.01083-18 (2018).","journal-title":"J. Virol."},{"key":"871_CR22","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1002\/jmv.25467","volume":"91","author":"A Engin","year":"2019","unstructured":"Engin, A., Aydin, H., Cinar, Z., Buyuktuna, S. A. & Bakir, M. Apoptosis and its relation with clinical course in patients with Crimean-Congo hemorrhagic fever. J. Med. Virol. 91, 1385\u20131393 (2019).","journal-title":"J. Med. Virol."},{"key":"871_CR23","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/INF.0000000000000530","volume":"34","author":"AS G\u00fcven","year":"2015","unstructured":"G\u00fcven, A. S. et al. Evaluation of serum perforin, caspase-3, sFasL and M-30 levels as apoptotic markers in children with Crimean-Congo hemorrhagic fever. Pediatr. Infect. Dis. J. 34, 208\u2013213 (2015).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"871_CR24","doi-asserted-by":"publisher","first-page":"e00616-19","DOI":"10.1128\/JVI.00616-19","volume":"93","author":"J Fuller","year":"2019","unstructured":"Fuller, J. et al. Rescue of infectious recombinant Hazara nairovirus from cDNA reveals the nucleocapsid protein DQVD caspase cleavage motif performs an essential role other than cleavage. J. Virol. 93, e00616-19 (2019).","journal-title":"J. Virol."},{"key":"871_CR25","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01627-12","author":"Y Wang","year":"2012","unstructured":"Wang, Y. et al. Structure of Crimean-Congo haemorraghic fever virus nucleoprotein: superhelical homo-oligomers and the role of caspase-3 cleavage. J. Virol. https:\/\/doi.org\/10.1128\/jvi.01627-12 (2012).","journal-title":"J. Virol."},{"key":"871_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41426-018-0192-0","volume":"7","author":"C Salata","year":"2018","unstructured":"Salata, C. et al. The DEVD motif of Crimean-Congo hemorrhagic fever virus nucleoprotein is essential for viral replication in tick cells. Emerg. Microbes Infect. 7, 190 (2018).","journal-title":"Emerg. Microbes Infect."},{"key":"871_CR27","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1099\/jgv.0.001211","volume":"100","author":"J Fuller","year":"2019","unstructured":"Fuller, J. et al. Hazara nairovirus elicits differential induction of apoptosis and nucleocapsid protein cleavage in mammalian and tick cells. J. Gen. Virol. 100, 392\u2013402 (2019).","journal-title":"J. Gen. Virol."},{"key":"871_CR28","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.76.14.7263-7275.2002","author":"AJ Sanchez","year":"2002","unstructured":"Sanchez, A. J., Vincent, M. J. & Nichol, S. T. Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus. J. Virol. https:\/\/doi.org\/10.1128\/jvi.76.14.7263-7275.2002 (2002).","journal-title":"J. Virol."},{"key":"871_CR29","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.80.1.514-525.2006","author":"AJ Sanchez","year":"2006","unstructured":"Sanchez, A. J., Vincent, M. J., Erickson, B. R. & Nichol, S. T. Crimean-Congo hemorrhagic fever virus glycoprotein precursor is cleaved by furin-like and SKI-1 proteases to generate a novel 38-kilodalton glycoprotein. J. Virol. https:\/\/doi.org\/10.1128\/jvi.80.1.514-525.2006 (2006).","journal-title":"J. Virol."},{"key":"871_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008850","volume":"16","author":"N Freitas","year":"2020","unstructured":"Freitas, N. et al. The interplays between Crimean-Congo hemorrhagic fever virus (CCHFV) M segment-encoded accessory proteins and structural proteins promote virus assembly and infectivity. PLoS Pathog. 16, e1008850 (2020).","journal-title":"PLoS Pathog."},{"key":"871_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/v13020353","author":"RJG Hulswit","year":"2021","unstructured":"Hulswit, R. J. G., Paesen, G. C., Bowden, T. A. & Shi, X. Recent advances in Bunyavirus glycoprotein research: precursor processing, receptor binding and structure. Viruses https:\/\/doi.org\/10.3390\/v13020353 (2021).","journal-title":"Viruses"},{"key":"871_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.virol.2013.05.030","volume":"444","author":"AR Garrison","year":"2013","unstructured":"Garrison, A. R. et al. Crimean-Congo hemorrhagic fever virus utilizes a clathrin- and early endosome-dependent entry pathway. Virology 444, 45\u201354 (2013).","journal-title":"Virology"},{"key":"871_CR33","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.1128\/JVI.79.10.6152-6161.2005","volume":"79","author":"A Bertolotti-Ciarlet","year":"2005","unstructured":"Bertolotti-Ciarlet, A. et al. Cellular localization and antigenic characterization of Crimean-Congo hemorrhagic fever virus glycoproteins. J. Virol. 79, 6152\u20136161 (2005).","journal-title":"J. Virol."},{"key":"871_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2006.11.023","author":"BR Erickson","year":"2007","unstructured":"Erickson, B. R., Deyde, V., Sanchez, A. J., Vincent, M. J. & Nichol, S. T. N-linked glycosylation of Gn (but not Gc) is important for Crimean Congo hemorrhagic fever virus glycoprotein localization and transport. Virology https:\/\/doi.org\/10.1016\/j.virol.2006.11.023 (2007).","journal-title":"Virology"},{"key":"871_CR35","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.77.16.8640-8649.2003","author":"MJ Vincent","year":"2003","unstructured":"Vincent, M. J. et al. Crimean-Congo hemorrhagic fever virus glycoprotein proteolytic processing by subtilase SKI-1. J. Virol. https:\/\/doi.org\/10.1128\/jvi.77.16.8640-8649.2003 (2003).","journal-title":"J. Virol."},{"key":"871_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.antiviral.2013.07.006","volume":"100","author":"DA Bente","year":"2013","unstructured":"Bente, D. A. et al. Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antivir. Res. 100, 159\u2013189 (2013).","journal-title":"Antivir. Res."},{"key":"871_CR37","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00752-06","author":"VM Deyde","year":"2006","unstructured":"Deyde, V. M., Khristova, M. L., Rollin, P. E., Ksiazek, T. G. & Nichol, S. T. Crimean-Congo hemorrhagic fever virus genomics and global diversity. J. Virol. https:\/\/doi.org\/10.1128\/jvi.00752-06 (2006).","journal-title":"J. Virol."},{"key":"871_CR38","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/78654","volume":"6","author":"Z-y Yang","year":"2000","unstructured":"Yang, Z.-y et al. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat. Med. 6, 886\u2013889 (2000).","journal-title":"Nat. Med."},{"key":"871_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.virol.2008.10.029","volume":"383","author":"JR Francica","year":"2009","unstructured":"Francica, J. R., Matukonis, M. K. & Bates, P. Requirements for cell rounding and surface protein down-regulation by Ebola virus glycoprotein. Virology 383, 237\u2013247 (2009).","journal-title":"Virology"},{"key":"871_CR40","doi-asserted-by":"publisher","first-page":"eaaw9535","DOI":"10.1126\/sciadv.aaw9535","volume":"5","author":"JW Golden","year":"2019","unstructured":"Golden, J. W. et al. GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection. Sci. Adv. 5, eaaw9535 (2019).","journal-title":"Sci. Adv."},{"key":"871_CR41","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3390\/microorganisms8050775","volume":"8","author":"SR Welch","year":"2020","unstructured":"Welch, S. R. et al. The Crimean-Congo hemorrhagic fever virus NSm protein is dispensable for growth in vitro and disease in Ifnar\u2212\/\u2212 mice. Microorganisms 8, 775 (2020).","journal-title":"Microorganisms"},{"key":"871_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/srep35819","volume":"6","author":"H Xia","year":"2016","unstructured":"Xia, H. et al. Transstadial transmission and long-term association of Crimean-Congo hemorrhagic fever virus in ticks shapes genome plasticity. Sci. Rep. 6, 35819 (2016).","journal-title":"Sci. Rep."},{"key":"871_CR43","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.63906","volume":"10","author":"DW Hawman","year":"2021","unstructured":"Hawman, D. W. et al. Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus. eLife 10, e63906 (2021).","journal-title":"eLife"},{"key":"871_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2003.09.042","author":"JE Honig","year":"2004","unstructured":"Honig, J. E., Osborne, J. C. & Nichol, S. T. Crimean-Congo hemorrhagic fever virus genome L RNA segment and encoded protein. Virology https:\/\/doi.org\/10.1016\/j.virol.2003.09.042 (2004).","journal-title":"Virology"},{"key":"871_CR45","doi-asserted-by":"publisher","first-page":"19686","DOI":"10.1074\/jbc.RA118.004373","volume":"293","author":"T Holm","year":"2018","unstructured":"Holm, T. et al. Biochemical and structural studies reveal differences and commonalities among cap-snatching endonucleases from segmented negative-strand RNA viruses. J. Biol. Chem. 293, 19686\u201319698 (2018).","journal-title":"J. Biol. Chem."},{"key":"871_CR46","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.virol.2003.09.042","volume":"321","author":"JE Honig","year":"2004","unstructured":"Honig, J. E., Osborne, J. C. & Nichol, S. T. Crimean\u2013Congo hemorrhagic fever virus genome L RNA segment and encoded protein. Virology 321, 29\u201335 (2004).","journal-title":"Virology"},{"key":"871_CR47","doi-asserted-by":"publisher","first-page":"10219","DOI":"10.1128\/JVI.01643-15","volume":"89","author":"JR Spengler","year":"2015","unstructured":"Spengler, J. R. et al. RIG-I mediates an antiviral response to Crimean-Congo hemorrhagic fever virus. J. Virol. 89, 10219\u201310229 (2015).","journal-title":"J. Virol."},{"key":"871_CR48","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1016\/j.celrep.2017.08.040","volume":"20","author":"FEM Scholte","year":"2017","unstructured":"Scholte, F. E. M. et al. Crimean-Congo hemorrhagic fever virus suppresses innate immune responses via a ubiquitin and ISG15 specific protease. Cell Rep. 20, 2396\u20132407 (2017).","journal-title":"Cell Rep."},{"key":"871_CR49","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41579-018-0020-5","volume":"16","author":"Y-C Perng","year":"2018","unstructured":"Perng, Y.-C. & Lenschow, D. J. ISG15 in antiviral immunity and beyond. Nat. Rev. Microbiol. 16, 423\u2013439 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"871_CR50","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01065-19","author":"FEM Scholte","year":"2019","unstructured":"Scholte, F. E. M. et al. Stable occupancy of the Crimean-Congo hemorrhagic fever virus-encoded deubiquitinase blocks viral infection. mBio https:\/\/doi.org\/10.1128\/mBio.01065-19 (2019).","journal-title":"mBio"},{"key":"871_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008610","volume":"14","author":"S Devignot","year":"2020","unstructured":"Devignot, S., Kromer, T., Mirazimi, A. & Weber, F. ISG15 overexpression compensates the defect of Crimean-Congo hemorrhagic fever virus polymerase bearing a protease-inactive ovarian tumor domain. PLoS Negl. Trop. Dis. 14, e0008610 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"871_CR52","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1128\/JVI.03252-12","volume":"87","author":"GC Capodagli","year":"2013","unstructured":"Capodagli, G. C., Deaton, M. K., Baker, E. A., Lumpkin, R. J. & Pegan, S. D. Diversity of ubiquitin and ISG15 specificity among nairoviruses\u2019 viral ovarian tumor domain proteases. J. Virol. 87, 3815\u20133827 (2013).","journal-title":"J. Virol."},{"key":"871_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007515","volume":"15","author":"JV Dzimianski","year":"2019","unstructured":"Dzimianski, J. V. et al. Probing the impact of nairovirus genomic diversity on viral ovarian tumor domain protease (vOTU) structure and deubiquitinase activity. PLoS Pathog. 15, e1007515 (2019).","journal-title":"PLoS Pathog."},{"key":"871_CR54","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3390\/v13020314","volume":"13","author":"SS Leventhal","year":"2021","unstructured":"Leventhal, S. S., Wilson, D., Feldmann, H. & Hawman, D. W. A look into Bunyavirales genomes: functions of non-structural (NS) proteins. Viruses 13, 314 (2021).","journal-title":"Viruses"},{"key":"871_CR55","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1099\/vir.0.056374-0","volume":"94","author":"Z Zhou","year":"2013","unstructured":"Zhou, Z. et al. Reassortment and migration analysis of Crimean\u2013Congo haemorrhagic fever virus. J. Gen. Virol. 94, 2536\u20132548 (2013).","journal-title":"J. Gen. Virol."},{"key":"871_CR56","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4269\/ajtmh.21-0685","volume":"106","author":"S Balinandi","year":"2021","unstructured":"Balinandi, S. et al. Clinical and molecular epidemiology of Crimean-Congo hemorrhagic fever in humans in Uganda, 2013\u20132019. Am. J. Trop. Med. Hyg. 106, 88\u201398 (2021).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"871_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9020438","author":"EM Wampande","year":"2021","unstructured":"Wampande, E. M. et al. Phylogenetic characterization of Crimean-Congo hemorrhagic fever virus detected in African blue ticks feeding on cattle in a Ugandan abattoir. Microorganisms https:\/\/doi.org\/10.3390\/microorganisms9020438 (2021).","journal-title":"Microorganisms"},{"key":"871_CR58","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3201\/eid1801.111040","volume":"18","author":"A Estrada-Pe\u00f1a","year":"2012","unstructured":"Estrada-Pe\u00f1a, A. et al. Crimean-Congo hemorrhagic fever virus in ticks, southwestern Europe, 2010. Emerg. Infect. Dis. 18, 179\u2013180 (2012).","journal-title":"Emerg. Infect. Dis."},{"key":"871_CR59","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.80121-0","author":"R Hewson","year":"2004","unstructured":"Hewson, R. et al. Evidence of segment reassortment in Crimean-Congo haemorrhagic fever virus. J. Gen. Virol. https:\/\/doi.org\/10.1099\/vir.0.80121-0 (2004).","journal-title":"J. Gen. Virol."},{"key":"871_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-9-90","volume":"9","author":"K Midilli","year":"2009","unstructured":"Midilli, K. et al. The first clinical case due to AP92 like strain of Crimean-Congo hemorrhagic fever virus and a field survey. BMC Infect. Dis. 9, 90 (2009).","journal-title":"BMC Infect. Dis."},{"key":"871_CR61","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3201\/eid1503.080687","volume":"15","author":"T Gunes","year":"2009","unstructured":"Gunes, T. et al. Crimean-Congo hemorrhagic fever virus in high-risk population, Turkey. Emerg. Infect. Dis. 15, 461\u2013464 (2009).","journal-title":"Emerg. Infect. Dis."},{"key":"871_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009384","volume":"15","author":"V Msimang","year":"2021","unstructured":"Msimang, V. et al. Risk factors associated with exposure to Crimean-Congo haemorrhagic fever virus in animal workers and cattle, and molecular detection in ticks, South Africa. PLoS Negl. Trop. Dis. 15, e0009384 (2021).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"871_CR63","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jinf.2009.01.014","volume":"58","author":"N Elaldi","year":"2009","unstructured":"Elaldi, N. et al. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. J. Infect. 58, 238\u2013244 (2009).","journal-title":"J. Infect."},{"key":"871_CR64","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/jmedent\/15.4.307","volume":"15","author":"H Hoogstraal","year":"1979","unstructured":"Hoogstraal, H. Review article: the epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J. Med. Entomol. 15, 307\u2013417 (1979).","journal-title":"J. Med. Entomol."},{"key":"871_CR65","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/S1473-3099(16)30453-4","volume":"16","author":"TH Mallhi","year":"2016","unstructured":"Mallhi, T. H., Khan, Y. H., Sarriff, A. & Khan, A. H. Crimean-Congo haemorrhagic fever virus and Eid-ul-Adha festival in Pakistan. Lancet Infect. Dis. 16, 1332\u20131333 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"871_CR66","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijid.2015.06.029","volume":"38","author":"H Leblebicioglu","year":"2015","unstructured":"Leblebicioglu, H. et al. Consensus report: preventive measures for Crimean-Congo hemorrhagic fever during Eid-al-Adha festival. Int. J. Infect. Dis. 38, 9\u201315 (2015).","journal-title":"Int. J. Infect. Dis."},{"key":"871_CR67","doi-asserted-by":"publisher","first-page":"387.e1","DOI":"10.1016\/j.cmi.2015.11.024","volume":"22","author":"H Leblebicioglu","year":"2016","unstructured":"Leblebicioglu, H. et al. Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002\u20132014: a multicentre retrospective cross-sectional study. Clin. Microbiol. Infect. 22, 387.e1\u2013387.e4 (2016).","journal-title":"Clin. Microbiol. Infect."},{"key":"871_CR68","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0140-6736(95)91323-8","volume":"346","author":"JA Khan","year":"1995","unstructured":"Khan, J. A. et al. Crimean Congo-haemorrhagic fever treated with oral ribavirin. Lancet 346, 472\u2013475 (1995).","journal-title":"Lancet"},{"key":"871_CR69","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ijid.2014.12.047","volume":"33","author":"NY Pshenichnaya","year":"2015","unstructured":"Pshenichnaya, N. Y. & Nenadskaya, S. A. Probable Crimean-Congo hemorrhagic fever virus transmission occurred after aerosol-generating medical procedures in Russia: nosocomial cluster. Int. J. Infect. Dis. 33, 120\u2013122 (2015).","journal-title":"Int. J. Infect. Dis."},{"key":"871_CR70","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ijid.2016.02.1008","volume":"45","author":"NY Pshenichnaya","year":"2016","unstructured":"Pshenichnaya, N. Y., Sydenko, I. S., Klinovaya, E. P., Romanova, E. B. & Zhuravlev, A. S. Possible sexual transmission of Crimean-Congo hemorrhagic fever. Int. J. Infect. Dis. 45, 109\u2013111 (2016).","journal-title":"Int. J. Infect. Dis."},{"key":"871_CR71","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2019-001955","volume":"5","author":"S Rugarabamu","year":"2020","unstructured":"Rugarabamu, S. et al. Forty-two years of responding to Ebola virus outbreaks in sub-Saharan Africa: a review. BMJ Glob. Health 5, e001955 (2020).","journal-title":"BMJ Glob. Health"},{"key":"871_CR72","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s13071-020-04074-6","volume":"13","author":"S Kar","year":"2020","unstructured":"Kar, S. et al. Crimean-Congo hemorrhagic fever virus in tortoises and Hyalomma aegyptium ticks in East Thrace, Turkey: potential of a cryptic transmission cycle. Parasit. Vectors 13, 201 (2020).","journal-title":"Parasit. Vectors"},{"key":"871_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(06)70435-2","author":"O Ergonul","year":"2006","unstructured":"Ergonul, O. Crimean-Congo haemorrhagic fever. Lancet Infect. Dis. https:\/\/doi.org\/10.1016\/s1473-3099(06)70435-2 (2006).","journal-title":"Lancet Infect. Dis."},{"key":"871_CR74","doi-asserted-by":"publisher","first-page":"S794","DOI":"10.1093\/clinids\/11.Supplement_4.S794","volume":"11","author":"R Swanepoel","year":"1989","unstructured":"Swanepoel, R. et al. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev. Infect. Dis. 11, S794\u2013S800 (1989).","journal-title":"Rev. Infect. Dis."},{"key":"871_CR75","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4269\/ajtmh.1987.36.120","volume":"36","author":"R Swanepoel","year":"1987","unstructured":"Swanepoel, R. et al. Epidemiologic and clinical features of Crimean-Congo hemorrhagic fever in southern Africa. Am. J. Trop. Med. Hyg. 36, 120\u2013132 (1987).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"871_CR76","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1099\/jmm.0.45865-0","volume":"54","author":"M Bakir","year":"2005","unstructured":"Bakir, M. et al. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J. Med. Microbiol. 54, 385\u2013389 (2005).","journal-title":"J. Med. Microbiol."},{"key":"871_CR77","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1469-0691.2006.01445.x","volume":"12","author":"O Ergonul","year":"2006","unstructured":"Ergonul, O., Celikbas, A., Baykam, N., Eren, S. & Dokuzoguz, B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin. Microbiol. Infect. 12, 551\u2013554 (2006).","journal-title":"Clin. Microbiol. Infect."},{"key":"871_CR78","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ijid.2007.09.010","volume":"12","author":"MA \u00c7evik","year":"2008","unstructured":"\u00c7evik, M. A. et al. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int. J. Infect. Dis. 12, 374\u2013379 (2008).","journal-title":"Int. J. Infect. Dis."},{"key":"871_CR79","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3201\/eid2207.151782","volume":"22","author":"AS Kleib","year":"2016","unstructured":"Kleib, A. S. et al. Crimean-Congo hemorrhagic fever with acute subdural hematoma, Mauritania, 2012. Emerg. Infect. Dis. 22, 1305\u20131306 (2016).","journal-title":"Emerg. Infect. Dis."},{"key":"871_CR80","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4103\/ijpvm.IJPVM_391_18","volume":"10","author":"H Hatami","year":"2019","unstructured":"Hatami, H., Qaderi, S. & Omid, A. M. Investigation of Crimean-Congo hemorrhagic fever in patients admitted in Antani Hospital, Kabul, Afghanistan, 2017\u20132018. Int. J. Prev. Med. 10, 117 (2019).","journal-title":"Int. J. Prev. Med."},{"key":"871_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-022-03303-z","volume":"16","author":"S Qaderi","year":"2022","unstructured":"Qaderi, S., Hatami, H., Omid, A. M. & Sayad, J. Vaginal bleeding as a sign of Crimean-Congo hemorrhagic fever infection: a case report. J. Med. Case Rep. 16, 76 (2022).","journal-title":"J. Med. Case Rep."},{"key":"871_CR82","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7883\/yoken.JJID.2014.566","volume":"69","author":"A Bastug","year":"2016","unstructured":"Bastug, A. et al. Crimean-Congo hemorrhagic fever: prognostic factors and the association of leukocyte counts with mortality. Jpn J. Infect. Dis. 69, 51\u201355 (2016).","journal-title":"Jpn J. Infect. Dis."},{"issue":"Suppl. 1","key":"871_CR83","doi-asserted-by":"publisher","first-page":"S352","DOI":"10.1093\/ofid\/ofx163.850","volume":"4","author":"F Aksoy","year":"2017","unstructured":"Aksoy, F., Yilmaz, G., Kaya, S., Karahan, S. C. & Koksal, I. The prognostic importance of platelet indices in patients with Crimean-Congo hemorrhagic fever. Open Forum Infect. Dis. 4\u00a0(Suppl. 1), S352\u2013S353 (2017).","journal-title":"Open Forum Infect. Dis."},{"key":"871_CR84","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1093\/cid\/cit527","volume":"57","author":"B Dokuzoguz","year":"2013","unstructured":"Dokuzoguz, B. et al. Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality. Clin. Infect. Dis. 57, 1270\u20131274 (2013).","journal-title":"Clin. Infect. Dis."},{"key":"871_CR85","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/jmv.24312","volume":"88","author":"A Papa","year":"2015","unstructured":"Papa, A. et al. Cytokines as biomarkers of Crimean-Congo hemorrhagic fever. J. Med. Virol. 88, 21\u201327 (2015).","journal-title":"J. Med. Virol."},{"key":"871_CR86","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1128\/CVI.00530-09","volume":"17","author":"A Saksida","year":"2010","unstructured":"Saksida, A. et al. Interacting roles of immune mechanisms and viral load in the pathogenesis of Crimean-Congo hemorrhagic fever. Clin. Vaccin. Immunol. 17, 1086\u20131093 (2010).","journal-title":"Clin. Vaccin. Immunol."},{"key":"871_CR87","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1086\/500836","volume":"193","author":"O Ergonul","year":"2006","unstructured":"Ergonul, O., Tuncbilek, S., Baykam, N., Celikbas, A. & Dokuzoguz, B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-\u03b1 in patients with Crimean-Congo hemorrhagic fever. J. Infect. Dis. 193, 941\u2013944 (2006).","journal-title":"J. Infect. Dis."},{"key":"871_CR88","doi-asserted-by":"publisher","first-page":"18952","DOI":"10.2807\/ese.13.33.18952-en","volume":"13","author":"A Papa","year":"2008","unstructured":"Papa, A. et al. A case of Crimean-Congo haemorrhagic fever in Greece, June 2008. Eurosurveillance 13, 18952 (2008).","journal-title":"Eurosurveillance"},{"key":"871_CR89","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.trstmh.2005.03.002","volume":"99","author":"B Jamil","year":"2005","unstructured":"Jamil, B. et al. Crimean-Congo hemorrhagic fever: experience at a tertiary care hospital in Karachi, Pakistan. Trans. R. Soc. Trop. Med. Hyg. 99, 577\u2013584 (2005).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"871_CR90","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1086\/422000","volume":"39","author":"\u00d6 Erg\u00f6n\u00fcl","year":"2004","unstructured":"Erg\u00f6n\u00fcl, \u00d6. et al. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin. Infect. Dis. 39, 284\u2013287 (2004).","journal-title":"Clin. Infect. Dis."},{"key":"871_CR91","doi-asserted-by":"publisher","first-page":"S801","DOI":"10.1093\/clinids\/11.Supplement_4.S801","volume":"11","author":"AJ Shepherd","year":"1989","unstructured":"Shepherd, A. J., Swanepoel, R. & Leman, P. A. Antibody response in Crimean-Congo hemorrhagic fever. Rev. Infect. Dis. 11, S801\u2013S806 (1989).","journal-title":"Rev. Infect. Dis."},{"key":"871_CR92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006149","volume":"11","author":"D Goedhals","year":"2017","unstructured":"Goedhals, D., Paweska, J. T. & Burt, F. J. Long-lived CD8+ T cell responses following Crimean-Congo haemorrhagic fever virus infection. PLoS Negl. Trop. Dis. 11, e0006149 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"871_CR93","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1086\/521244","volume":"45","author":"MA \u00c7evik","year":"2007","unstructured":"\u00c7evik, M. A. et al. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin. Infect. Dis. 45, e96\u2013e100 (2007).","journal-title":"Clin. Infect. Dis."},{"key":"871_CR94","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3201\/eid1311.070222","volume":"13","author":"D Duh","year":"2007","unstructured":"Duh, D. et al. Viral load as predictor of Crimean-Congo hemorrhagic fever outcome. Emerg. Infect. Dis. 13, 1769\u20131772 (2007).","journal-title":"Emerg. Infect. Dis."},{"key":"871_CR95","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jcv.2006.04.007","volume":"36","author":"A Papa","year":"2006","unstructured":"Papa, A. et al. Cytokine levels in Crimean-Congo hemorrhagic fever. J. Clin. Virol. 36, 272\u2013276 (2006).","journal-title":"J. Clin. Virol."},{"key":"871_CR96","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.diagmicrobio.2013.12.015","volume":"79","author":"K Ergunay","year":"2014","unstructured":"Ergunay, K. et al. Antibody responses and viral load in patients with Crimean-Congo hemorrhagic fever: a comprehensive analysis during the early stages of the infection. Diagn. Microbiol. Infect. Dis. 79, 31\u201336 (2014).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"871_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-416","volume":"14","author":"S Kaya","year":"2014","unstructured":"Kaya, S. et al. Sequential determination of serum viral titers, virus-specific IgG antibodies, and TNF-\u03b1, IL-6, IL-10, and IFN-\u03b3 levels in patients with Crimean-Congo hemorrhagic fever. BMC Infect. Dis. 14, 416 (2014).","journal-title":"BMC Infect. Dis."},{"key":"871_CR98","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1017\/S0950268800068576","volume":"113","author":"FJ Burt","year":"1994","unstructured":"Burt, F. J., Leman, P. A., Abbott, J. C. & Swanepoel, R. Serodiagnosis of Crimean-Congo haemorrhagic fever. Epidemiol. Infect. 113, 551\u2013562 (1994).","journal-title":"Epidemiol. Infect."},{"key":"871_CR99","first-page":"189","volume":"1","author":"OT Papadopoulos","year":"1980","unstructured":"Papadopoulos, O. T. & Koptopoulos, G. Crimean-Congo hemorrhagic fever (CCHF) in Greece: isolation of the virus from Rhipicephalus bursa ticks and a preliminary serological survey. Zentbl. Bakteriol. Hyg. Abt. 1, 189\u2013193 (1980).","journal-title":"Zentbl. Bakteriol. Hyg. Abt."},{"key":"871_CR100","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ttbdis.2013.04.003","volume":"4","author":"A Papa","year":"2013","unstructured":"Papa, A. et al. Factors associated with IgG positivity to Crimean-Congo hemorrhagic fever virus in the area with the highest seroprevalence in Greece. Ticks Tick Borne Dis. 4, 417\u2013420 (2013).","journal-title":"Ticks Tick Borne Dis."},{"key":"871_CR101","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.ttbdis.2014.04.008","volume":"5","author":"A Papa","year":"2014","unstructured":"Papa, A. et al. A novel AP92-like Crimean-Congo hemorrhagic fever virus strain, Greece. Ticks Tick Borne Dis. 5, 590\u2013593 (2014).","journal-title":"Ticks Tick Borne Dis."},{"key":"871_CR102","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3109\/00365548.2011.623313","volume":"44","author":"S Arslan","year":"2012","unstructured":"Arslan, S. & Engin, A. Relationship between NF-\u03baB1 and NF-\u03baBIA genetic polymorphisms and Crimean-Congo hemorrhagic fever. Scand. J. Infect. Dis. 44, 138\u2013143 (2012).","journal-title":"Scand. J. Infect. Dis."},{"key":"871_CR103","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1002\/jmv.24174","volume":"87","author":"S Arslan","year":"2015","unstructured":"Arslan, S., Engin, A., \u00d6zbil\u00fcm, N. & Bak\u0131r, M. Toll-like receptor 7 Gln11Leu, c.4-151A\/G, and +1817G\/T polymorphisms in Crimean Congo hemorrhagic fever. J. Med. Virol. 87, 1090\u20131095 (2015).","journal-title":"J. Med. Virol."},{"key":"871_CR104","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/jmv.24456","volume":"88","author":"N Elaldi","year":"2016","unstructured":"Elaldi, N. et al. Relationship between IFNA1, IFNA5, IFNA10, and IFNA17 gene polymorphisms and Crimean-Congo hemorrhagic fever prognosis in a Turkish population range. J. Med. Virol. 88, 1159\u20131167 (2016).","journal-title":"J. Med. Virol."},{"key":"871_CR105","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.micinf.2010.07.012","volume":"12","author":"A Engin","year":"2010","unstructured":"Engin, A. et al. Toll-like receptor 8 and 9 polymorphisms in Crimean-Congo hemorrhagic fever. Microbes Infect. 12, 1071\u20131078 (2010).","journal-title":"Microbes Infect."},{"key":"871_CR106","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/jmv.24924","volume":"90","author":"S K\u0131z\u0131lda\u011f","year":"2018","unstructured":"K\u0131z\u0131lda\u011f, S., Arslan, S., \u00d6zbil\u00fcm, N., Engin, A. & Bak\u0131r, M. Effect of TLR10 (2322A\/G, 720A\/C, and 992T\/A) polymorphisms on the pathogenesis of Crimean Congo hemorrhagic fever disease. J. Med. Virol. 90, 19\u201325 (2018).","journal-title":"J. Med. Virol."},{"key":"871_CR107","doi-asserted-by":"publisher","first-page":"e1038","DOI":"10.1016\/j.ijid.2013.06.005","volume":"17","author":"E Ak\u0131nc\u0131","year":"2013","unstructured":"Ak\u0131nc\u0131, E., Bodur, H., Mu\u015fabak, U. & Sa\u011fkan, R. I. The relationship between the human leukocyte antigen system and Crimean-Congo hemorrhagic fever in the Turkish population. Int. J. Infect. Dis. 17, e1038\u2013e1041 (2013).","journal-title":"Int. J. Infect. Dis."},{"key":"871_CR108","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3201\/eid1804.111374","volume":"18","author":"H Bodur","year":"2012","unstructured":"Bodur, H., Akinci, E., Ascioglu, S., \u00d6ng\u00fcr\u00fc, P. & Uyar, Y. Subclinical infections with Crimean-Congo hemorrhagic fever virus, Turkey. Emerg. Infect. Dis. 18, 640\u2013642 (2012).","journal-title":"Emerg. Infect. Dis."},{"key":"871_CR109","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0166-3542(93)90040-P","volume":"22","author":"GH Tignor","year":"1993","unstructured":"Tignor, G. H. & Hanham, C. A. Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection. Antivir. Res. 22, 309\u2013325 (1993).","journal-title":"Antivir. Res."},{"key":"871_CR110","doi-asserted-by":"publisher","first-page":"11089","DOI":"10.1128\/JVI.01383-10","volume":"84","author":"DA Bente","year":"2010","unstructured":"Bente, D. A. et al. Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. J. Virol. 84, 11089\u201311100 (2010).","journal-title":"J. Virol."},{"key":"871_CR111","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1099\/vir.0.019034-0","volume":"91","author":"S Bereczky","year":"2010","unstructured":"Bereczky, S. et al. Crimean\u2013Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice. J. Gen. Virol. 91, 1473\u20131477 (2010).","journal-title":"J. Gen. Virol."},{"key":"871_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69054-3","volume":"10","author":"C Ranadheera","year":"2020","unstructured":"Ranadheera, C. et al. Characterization of a novel STAT 2 knock-out hamster model of Crimean-Congo hemorrhagic fever virus pathogenesis. Sci. Rep. 10, 12378 (2020).","journal-title":"Sci. Rep."},{"key":"871_CR113","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1093\/infdis\/jit061","volume":"207","author":"M Zivcec","year":"2013","unstructured":"Zivcec, M. et al. Lethal Crimean-Congo hemorrhagic fever virus infection in interferon \u03b1\/\u03b2 receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy. J. Infect. Dis. 207, 1909\u20131921 (2013).","journal-title":"J. Infect. Dis."},{"key":"871_CR114","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002804","volume":"8","author":"L Oestereich","year":"2014","unstructured":"Oestereich, L. et al. Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever. PLoS Negl. Trop. Dis. 8, e2804 (2014).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"871_CR115","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.antiviral.2017.10.008","volume":"147","author":"SR Welch","year":"2017","unstructured":"Welch, S. R. et al. Identification of 2\u2032-deoxy-2\u2032-fluorocytidine as a potent inhibitor of Crimean-Congo hemorrhagic fever virus replication using a recombinant fluorescent reporter virus. Antivir. Res. 147, 91\u201399 (2017).","journal-title":"Antivir. Res."},{"key":"871_CR116","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.antiviral.2018.06.013","volume":"157","author":"DW Hawman","year":"2018","unstructured":"Hawman, D. W. et al. Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice. Antivir. Res. 157, 18\u201326 (2018).","journal-title":"Antivir. Res."},{"key":"871_CR117","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1016\/j.cell.2021.05.001","volume":"184","author":"JM Fels","year":"2021","unstructured":"Fels, J. M. et al. Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever. Cell 184, 3486\u20133501.e21 (2021).","journal-title":"Cell"},{"key":"871_CR118","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1089\/biores.2019.0057","volume":"9","author":"T Tipih","year":"2020","unstructured":"Tipih, T. & Burt, F. J. Crimean-Congo hemorrhagic fever virus: advances in vaccine development. Biores. Open Access 9, 137\u2013150 (2020).","journal-title":"Biores. Open Access"},{"key":"871_CR119","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010485","volume":"18","author":"JW Golden","year":"2022","unstructured":"Golden, J. W. et al. The host inflammatory response contributes to disease severity in Crimean-Congo hemorrhagic fever virus infected mice. PLoS Pathog. 18, e1010485 (2022).","journal-title":"PLoS Pathog."},{"key":"871_CR120","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00554-19","author":"DW Hawman","year":"2019","unstructured":"Hawman, D. W. et al. A Crimean-Congo hemorrhagic fever mouse model recapitulating human convalescence. J. Virol. https:\/\/doi.org\/10.1128\/JVI.00554-19 (2019).","journal-title":"J. Virol."},{"key":"871_CR121","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008183","volume":"15","author":"SR Welch","year":"2019","unstructured":"Welch, S. R. et al. Fluorescent Crimean-Congo hemorrhagic fever virus illuminates tissue tropism patterns and identifies early mononuclear phagocytic cell targets in Ifnar\u2212\/\u2212 mice. PLoS Pathog. 15, e1008183 (2019).","journal-title":"PLoS Pathog."},{"key":"871_CR122","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/ni1519","volume":"8","author":"CA Zampieri","year":"2007","unstructured":"Zampieri, C. A., Sullivan, N. J. & Nabel, G. J. Immunopathology of highly virulent pathogens: insights from Ebola virus. Nat. Immunol. 8, 1159\u20131164 (2007).","journal-title":"Nat. Immunol."},{"key":"871_CR123","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00281-017-0637-x","volume":"39","author":"CF Basler","year":"2017","unstructured":"Basler, C. F. Molecular pathogenesis of viral hemorrhagic fever. Semin. Immunopathol. 39, 551\u2013561 (2017).","journal-title":"Semin. Immunopathol."},{"key":"871_CR124","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9020279","author":"DW Hawman","year":"2021","unstructured":"Hawman, D. W. et al. T-cells and interferon gamma are necessary for survival following Crimean-Congo hemorrhagic fever virus infection in mice. Microorganisms https:\/\/doi.org\/10.3390\/microorganisms9020279 (2021).","journal-title":"Microorganisms"},{"key":"871_CR125","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix215","author":"JR Spengler","year":"2017","unstructured":"Spengler, J. R. et al. Crimean-Congo hemorrhagic fever in humanized mice reveals glial cells as primary targets of neurological infection. J. Infect. Dis. https:\/\/doi.org\/10.1093\/infdis\/jix215 (2017).","journal-title":"J. Infect. Dis."},{"key":"871_CR126","doi-asserted-by":"publisher","first-page":"104702","DOI":"10.1016\/j.antiviral.2019.104702","volume":"174","author":"M Zivcec","year":"2020","unstructured":"Zivcec, M., Spiropoulou, C. F. & Spengler, J. R. The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 2: vaccine efficacy studies. Antivir. Res. 174, 104702 (2020).","journal-title":"Antivir. Res."},{"key":"871_CR127","doi-asserted-by":"publisher","first-page":"104703","DOI":"10.1016\/j.antiviral.2019.104703","volume":"174","author":"EC Clarke","year":"2020","unstructured":"Clarke, E. C. & Bradfute, S. B. The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 1: potential effects on adaptive immunity and response to vaccination. Antivir. Res. 174, 104703 (2020).","journal-title":"Antivir. Res."},{"key":"871_CR128","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008094","volume":"14","author":"L Monsalve-Arteaga","year":"2020","unstructured":"Monsalve-Arteaga, L. et al. Seroprevalence of Crimean-Congo hemorrhagic fever in humans in the World Health Organization European region: a systematic review. PLoS Negl. Trop. Dis. 14, e0008094 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"871_CR129","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/jmv.23699","volume":"86","author":"D Yagci-Caglayik","year":"2014","unstructured":"Yagci-Caglayik, D., Korukluoglu, G. & Uyar, Y. Seroprevalence and risk factors of Crimean\u2013Congo hemorrhagic fever in selected seven provinces in Turkey. J. Med. Virol. 86, 306\u2013314 (2014).","journal-title":"J. Med. Virol."},{"key":"871_CR130","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007571","volume":"13","author":"H Bower","year":"2019","unstructured":"Bower, H. et al. Detection of Crimean-Congo haemorrhagic fever cases in a severe undifferentiated febrile illness outbreak in the Federal Republic of Sudan: a retrospective epidemiological and diagnostic cohort study. PLoS Negl. Trop. Dis. 13, e0007571 (2019).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"871_CR131","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1089\/vbz.2009.0247","volume":"10","author":"S Chinikar","year":"2010","unstructured":"Chinikar, S. et al. Geographical distribution and surveillance of Crimean-Congo hemorrhagic fever in Iran. Vector Borne Zoonotic Dis. 10, 705\u2013708 (2010).","journal-title":"Vector Borne Zoonotic Dis."},{"key":"871_CR132","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41564-018-0141-7","volume":"3","author":"E Haddock","year":"2018","unstructured":"Haddock, E. et al. A cynomolgus macaque model for Crimean-Congo haemorrhagic fever. Nat. Microbiol. 3, 556\u2013562 (2018).","journal-title":"Nat. Microbiol."},{"key":"871_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104858","author":"DW Hawman","year":"2020","unstructured":"Hawman, D. W. et al. Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques. Antivir. Res. https:\/\/doi.org\/10.1016\/j.antiviral.2020.104858 (2020).","journal-title":"Antivir. Res."},{"key":"871_CR134","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008637","volume":"14","author":"RW Cross","year":"2020","unstructured":"Cross, R. W. et al. Crimean-Congo hemorrhagic fever virus strains Hoti and Afghanistan cause viremia and mild clinical disease in cynomolgus monkeys. PLoS Negl. Trop. Dis. 14, e0008637 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"871_CR135","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008050","volume":"15","author":"DR Smith","year":"2019","unstructured":"Smith, D. R. et al. Persistent Crimean-Congo hemorrhagic fever virus infection in the testes and within granulomas of non-human primates with latent tuberculosis. PLoS Pathog. 15, e1008050 (2019).","journal-title":"PLoS Pathog."},{"key":"871_CR136","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2217\/fmb.12.139","volume":"8","author":"LL Coffey","year":"2013","unstructured":"Coffey, L. L., Forrester, N., Tsetsarkin, K., Vasilakis, N. & Weaver, S. C. Factors shaping the adaptive landscape for arboviruses: implications for the emergence of disease. Future Microbiol. 8, 155\u2013176 (2013).","journal-title":"Future Microbiol."},{"key":"871_CR137","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.50999","volume":"9","author":"BL Hua","year":"2020","unstructured":"Hua, B. L. et al. A single mutation in Crimean-Congo hemorrhagic fever virus discovered in ticks impairs infectivity in human cells. eLife 9, e50999 (2020).","journal-title":"eLife"},{"key":"871_CR138","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jinf.2009.08.006","volume":"59","author":"O Ergonul","year":"2009","unstructured":"Ergonul, O. Debate (see Elaldi N et al., Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. Journal of Infection 2009; 58: 238\u2013244): biases and misinterpretation in the assessment of the efficacy of oral ribavirin in the treatment of Crimean\u2013Congo hemorrhagic fever. J. Infect. 59, 284\u2013286 (2009).","journal-title":"J. Infect."},{"key":"871_CR139","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ijid.2014.08.016","volume":"29","author":"O Ergonul","year":"2014","unstructured":"Ergonul, O. Evidence supports ribavirin use in Crimean-Congo hemorrhagic fever. Int. J. Infect. Dis. 29, 296 (2014).","journal-title":"Int. J. Infect. Dis."},{"key":"871_CR140","doi-asserted-by":"publisher","first-page":"e799","DOI":"10.1016\/j.ijid.2013.02.030","volume":"17","author":"B Ceylan","year":"2013","unstructured":"Ceylan, B., Calica, A., Ak, O., Akkoyunlu, Y. & Turhan, V. Ribavirin is not effective against Crimean-Congo hemorrhagic fever: observations from the Turkish experience. Int. J. Infect. Dis. 17, e799\u2013e801 (2013).","journal-title":"Int. J. Infect. Dis."},{"key":"871_CR141","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1093\/infdis\/jiy163","volume":"217","author":"N Espy","year":"2018","unstructured":"Espy, N. et al. Ribavirin had demonstrable effects on the Crimean-Congo hemorrhagic fever virus (CCHFV) population and load in a patient with CCHF infection. J. Infect. Dis. 217, 1952\u20131956 (2018).","journal-title":"J. Infect. Dis."},{"key":"871_CR142","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jcv.2009.11.007","volume":"47","author":"I Koksal","year":"2010","unstructured":"Koksal, I. et al. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in eastern Black Sea region in Turkey. J. Clin. Virol. 47, 65\u201368 (2010).","journal-title":"J. Clin. Virol."},{"key":"871_CR143","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s10096-009-0728-2","volume":"28","author":"N Tasdelen Fisgin","year":"2009","unstructured":"Tasdelen Fisgin, N., Ergonul, O., Doganci, L. & Tulek, N. The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising. Eur. J. Clin. Microbiol. Infect. Dis. 28, 929\u2013933 (2009).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"871_CR144","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/jac\/dkr136","volume":"66","author":"S Ascioglu","year":"2011","unstructured":"Ascioglu, S., Leblebicioglu, H., Vahaboglu, H. & Chan, K. A. Ribavirin for patients with Crimean\u2013Congo haemorrhagic fever: a systematic review and meta-analysis. J. Antimicrob. Chemother. 66, 1215\u20131222 (2011).","journal-title":"J. Antimicrob. Chemother."},{"key":"871_CR145","first-page":"CD012713","volume":"6","author":"S Johnson","year":"2018","unstructured":"Johnson, S. et al. Ribavirin for treating Crimean Congo haemorrhagic fever. Cochrane Database Syst. Rev. 6, CD012713 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"871_CR146","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1093\/jac\/dkz328","volume":"74","author":"Z Arab-Bafrani","year":"2019","unstructured":"Arab-Bafrani, Z. et al. Identification of the crucial parameters regarding the efficacy of ribavirin therapy in Crimean\u2013Congo haemorrhagic fever (CCHF) patients: a systematic review and meta-analysis. J. Antimicrob. Chemother. 74, 3432\u20133439 (2019).","journal-title":"J. Antimicrob. Chemother."},{"key":"871_CR147","doi-asserted-by":"publisher","first-page":"105273","DOI":"10.1016\/j.antiviral.2022.105273","volume":"199","author":"Q Wang","year":"2022","unstructured":"Wang, Q. et al. In vitro and in vivo efficacy of a novel nucleoside analog H44 against Crimean\u2013Congo hemorrhagic fever virus. Antivir. Res. 199, 105273 (2022).","journal-title":"Antivir. Res."},{"key":"871_CR148","doi-asserted-by":"publisher","first-page":"445","DOI":"10.5578\/mb.20219813","volume":"55","author":"SA B\u00fcy\u00fcktuna","year":"2021","unstructured":"B\u00fcy\u00fcktuna, S. A. et al. [COVID-19 co-infection in a patient with Crimean Congo hemorrhagic fever: a case report]. Mikrobiyol. Bul. 55, 445\u2013451 (2021).","journal-title":"Mikrobiyol. Bul."},{"key":"871_CR149","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa2116044","volume":"386","author":"A Jayk Bernal","year":"2021","unstructured":"Jayk Bernal, A. et al. Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. N. Engl. J. Med. 386, 509\u2013520 (2021).","journal-title":"N. Engl. J. Med."},{"key":"871_CR150","doi-asserted-by":"publisher","first-page":"6679","DOI":"10.1128\/AAC.01156-16","volume":"60","author":"E Vanderlinden","year":"2016","unstructured":"Vanderlinden, E. et al. Distinct effects of T-705 (favipiravir) and ribavirin on influenza virus replication and viral RNA synthesis. Antimicrob. Agents Chemother. 60, 6679\u20136691 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"871_CR151","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.3390\/v12121423","volume":"12","author":"M Tampere","year":"2020","unstructured":"Tampere, M. et al. Novel broad-spectrum antiviral inhibitors targeting host factors essential for replication of pathogenic RNA viruses. Viruses 12, 1423 (2020).","journal-title":"Viruses"},{"key":"871_CR152","volume":"13","author":"SP Fabara","year":"2021","unstructured":"Fabara, S. P. et al. Crimean-Congo hemorrhagic fever beyond ribavirin: a systematic review. Cureus 13, e17842 (2021).","journal-title":"Cureus"},{"key":"871_CR153","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.antiviral.2011.02.010","volume":"90","author":"M Keshtkar-Jahromi","year":"2011","unstructured":"Keshtkar-Jahromi, M. et al. Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies. Antivir. Res. 90, 85\u201392 (2011).","journal-title":"Antivir. Res."},{"key":"871_CR154","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.antiviral.2017.08.014","volume":"146","author":"M Zivcec","year":"2017","unstructured":"Zivcec, M. et al. Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus. Antivir. Res. 146, 112\u2013120 (2017).","journal-title":"Antivir. Res."},{"key":"871_CR155","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/0049475513486642","volume":"43","author":"B Sharifi-Mood","year":"2013","unstructured":"Sharifi-Mood, B. et al. Efficacy of high-dose methylprednisolone in patients with Crimean-Congo haemorrhagic fever and severe thrombocytopenia. Trop. Doct. 43, 49\u201353 (2013).","journal-title":"Trop. Doct."},{"key":"871_CR156","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00460","author":"P Li","year":"2017","unstructured":"Li, P., Zheng, Y. & Chen, X. Drugs for autoimmune inflammatory diseases: from small molecule compounds to anti-TNF biologics. Front. Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2017.00460 (2017).","journal-title":"Front. Pharmacol."},{"key":"871_CR157","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nrd2805","volume":"9","author":"M Kopf","year":"2010","unstructured":"Kopf, M., Bachmann, M. F. & Marsland, B. J. Averting inflammation by targeting the cytokine environment. Nat. Rev. Drug Discov. 9, 703\u2013718 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"871_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e05675","volume":"6","author":"B Kumar","year":"2020","unstructured":"Kumar, B., Manjunathachar, H. V. & Ghosh, S. A review on Hyalomma species infestations on human and animals and progress on management strategies. Heliyon 6, e05675 (2020).","journal-title":"Heliyon"},{"key":"871_CR159","doi-asserted-by":"publisher","first-page":"e1046","DOI":"10.1016\/j.ijid.2013.05.005","volume":"17","author":"MG Gozel","year":"2013","unstructured":"Gozel, M. G. et al. Recommended precaution procedures protect healthcare workers from Crimean-Congo hemorrhagic fever virus. Int. J. Infect. Dis. 17, e1046\u2013e1050 (2013).","journal-title":"Int. J. Infect. Dis."},{"key":"871_CR160","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008834","volume":"14","author":"STI Pavel","year":"2020","unstructured":"Pavel, S. T. I., Yetiskin, H., Kalkan, A. & Ozdarendeli, A. Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model. PLoS Negl. Trop. Dis. 14, e0008834 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"871_CR161","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1089\/vbz.2015.1855","volume":"15","author":"J Kortekaas","year":"2015","unstructured":"Kortekaas, J. et al. Crimean-Congo hemorrhagic fever virus subunit vaccines induce high levels of neutralizing antibodies but no protection in STAT1 knockout mice. Vector Borne Zoonotic Dis. 15, 759\u2013764 (2015).","journal-title":"Vector Borne Zoonotic Dis."},{"key":"871_CR162","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1080\/22221751.2019.1601030","volume":"8","author":"FEM Scholte","year":"2019","unstructured":"Scholte, F. E. M. et al. Single-dose replicon particle vaccine provides complete protection against Crimean-Congo hemorrhagic fever virus in mice. Emerg. Microbes Infect. 8, 575\u2013578 (2019).","journal-title":"Emerg. Microbes Infect."},{"key":"871_CR163","doi-asserted-by":"publisher","first-page":"e02076-16","DOI":"10.1128\/JVI.02076-16","volume":"91","author":"J Hinkula","year":"2017","unstructured":"Hinkula, J. et al. Immunization with DNA plasmids coding for Crimean-Congo hemorrhagic fever virus capsid and envelope proteins and\/or virus-like particles induces protection and survival in challenged mice. J. Virol. 91, e02076-16 (2017).","journal-title":"J. Virol."},{"key":"871_CR164","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-44210-6","volume":"9","author":"SE Rodriguez","year":"2019","unstructured":"Rodriguez, S. E. et al. Vesicular stomatitis virus-based vaccine protects mice against Crimean-Congo hemorrhagic fever. Sci. Rep. 9, 7755 (2019).","journal-title":"Sci. Rep."},{"key":"871_CR165","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091516","volume":"9","author":"KR Buttigieg","year":"2014","unstructured":"Buttigieg, K. R. et al. A novel vaccine against Crimean-Congo haemorrhagic fever protects 100% of animals against lethal challenge in a mouse model. PLoS ONE 9, e91516 (2014).","journal-title":"PLoS ONE"},{"key":"871_CR166","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006628","volume":"12","author":"M Zivcec","year":"2018","unstructured":"Zivcec, M., Safronetz, D., Scott, D. P., Robertson, S. & Feldmann, H. Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge. PLoS Negl. Trop. Dis. 12, e0006628 (2018).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"871_CR167","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005908","volume":"11","author":"AR Garrison","year":"2017","unstructured":"Garrison, A. R. et al. A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models. PLoS Negl. Trop. Dis. 11, e0005908 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"871_CR168","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41564-020-00815-6","volume":"6","author":"DW Hawman","year":"2021","unstructured":"Hawman, D. W. et al. A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a cynomolgus macaque model. Nat. Microbiol. 6, 187\u2013195 (2021).","journal-title":"Nat. Microbiol."},{"key":"871_CR169","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01568-21","author":"S Appelberg","year":"2021","unstructured":"Appelberg, S. et al. Nucleoside-modified mRNA vaccines protect IFNAR\u2212\/\u2212 mice against Crimean Congo hemorrhagic fever virus infection. J. Virol. https:\/\/doi.org\/10.1128\/jvi.01568-21 (2021).","journal-title":"J. Virol."},{"key":"871_CR170","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9121491","author":"T Tipih","year":"2021","unstructured":"Tipih, T., Heise, M. & Burt, F. J. Immunogenicity of a DNA-based Sindbis replicon expressing Crimean\u2013Congo hemorrhagic fever virus nucleoprotein. Vaccines https:\/\/doi.org\/10.3390\/vaccines9121491 (2021).","journal-title":"Vaccines"},{"key":"871_CR171","doi-asserted-by":"publisher","first-page":"104188","DOI":"10.1016\/j.ebiom.2022.104188","volume":"82","author":"SS Leventhal","year":"2022","unstructured":"Leventhal, S. S. et al. Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challenge. eBioMedicine 82, 104188 (2022).","journal-title":"eBioMedicine"},{"key":"871_CR172","doi-asserted-by":"publisher","first-page":"6015","DOI":"10.1016\/j.vaccine.2017.05.031","volume":"35","author":"SD Dowall","year":"2017","unstructured":"Dowall, S. D., Carroll, M. W. & Hewson, R. Development of vaccines against Crimean-Congo haemorrhagic fever virus. Vaccine 35, 6015\u20136023 (2017).","journal-title":"Vaccine"},{"key":"871_CR173","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00293-9","volume":"6","author":"JJ Suschak","year":"2021","unstructured":"Suschak, J. J. et al. A CCHFV DNA vaccine protects against heterologous challenge and establishes GP38 as immunorelevant in mice. npj Vaccines 6, 31 (2021).","journal-title":"npj Vaccines"},{"key":"871_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2022.09.016","author":"DW Hawman","year":"2023","unstructured":"Hawman, D. W. et al. Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model. Mol. Ther. https:\/\/doi.org\/10.1016\/j.ymthe.2022.09.016 (2023).","journal-title":"Mol. Ther."},{"key":"871_CR175","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156637","volume":"11","author":"SD Dowall","year":"2016","unstructured":"Dowall, S. D. et al. Protective effects of a modified vaccinia Ankara-based vaccine candidate against Crimean-Congo haemorrhagic fever virus require both cellular and humoral responses. PLoS ONE 11, e0156637 (2016).","journal-title":"PLoS ONE"},{"key":"871_CR176","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/21645515.2015.1078045","volume":"12","author":"SD Dowall","year":"2016","unstructured":"Dowall, S. D. et al. A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease. Hum. Vaccin. Immunother. 12, 519\u2013527 (2016).","journal-title":"Hum. Vaccin. Immunother."},{"key":"871_CR177","doi-asserted-by":"publisher","DOI":"10.3390\/v11100953","author":"CEM Gruber","year":"2019","unstructured":"Gruber, C. E. M. et al. Geographical variability affects CCHFV detection by RT-PCR: a tool for in-silico evaluation of molecular assays. Viruses https:\/\/doi.org\/10.3390\/v11100953 (2019).","journal-title":"Viruses"},{"key":"871_CR178","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93319-0","volume":"11","author":"N Shrivastava","year":"2021","unstructured":"Shrivastava, N. et al. Development of double antibody sandwich ELISA as potential diagnostic tool for rapid detection of Crimean-Congo hemorrhagic fever virus. Sci. Rep. 11, 14699 (2021).","journal-title":"Sci. Rep."}],"container-title":["Nature Reviews Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41579-023-00871-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41579-023-00871-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41579-023-00871-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T17:35:09Z","timestamp":1733938509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41579-023-00871-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,14]]},"references-count":178,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["871"],"URL":"https:\/\/doi.org\/10.1038\/s41579-023-00871-9","relation":{},"ISSN":["1740-1526","1740-1534"],"issn-type":[{"value":"1740-1526","type":"print"},{"value":"1740-1534","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,14]]},"assertion":[{"value":"13 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.W.H. and H.F. are listed as inventors on US patent application number 63\/365,015 \u2018Replicating RNA vaccine for Crimean\u2013Congo hemorrhagic fever virus\u2019.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}